Livanova (LIVN) PT Raised to $58 at Barclays

Barclays analyst Matt Miksic raised the price target on Livanova (NASDAQ: LIVN) to $58.00 (from $55.00) while maintaining a Equalweight rating.

The analyst comments "Revising Our Estimates: We have raised our sales projection by ~3% in 2025, in line with management’s commentary and updated outlook, and raised our sales projections by ~9% on average per year in 2026 and beyond. We have also raised our EPS estimate by ~3% in 2025 and by 5-6% on average per year in 2026 and beyond. For additional details on Q2 performance vs. our estimates and consensus, please see our note, Strong Beat on Sales and EPS, Driven by DD Growth in Europe Across All Businesses; Guide Raised Above Street, published Aug 6). Raising Our Price Target from $55 to $58: Our $58 price target (up from $55) is based on a 8.0x EV/EBITDA multiple (unchanged) on our projected NTM EBITDA, 1 year forward of $396 mil (up from $385 mil previously). Our target multiple is a slight premium to the stock's current ~7.0x multiple on NTM EBITDA and roughly in line with the stock’s YTD multiple of ~8.0x."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Aurora Spine settles patent dispute, secures $600K insider loan
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery